Intended for UK patients and members of the public
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintDiscontinued Other versions of this medicine may still be available. Information for reference purposes.
Product Documentation
Last updated on this site: 29 May 2026
Description of update:
1: To update sections 4.4 and 4.8 of the SmPC and PIL of the finished products Gabapentin Accord hard capsules to bring the product information in line with PRAC update (PSUSA/00001499/202502) - for causal relationship between gabapentin and withdrawal reactions following dose reduction, and exacerbation of myasthenia gravis.
2: To update sections 4.2, 4.4, 4.8 and 4.9 of the SmPC of the finished products in line with MHRA review to improve communication of risks. Consequently, the label and PIL are also being updated accordingly. In addition, editorial updates have been made to the PIL and cartons including QRD updates to the PIL.
Date of approval: 02/04/2026
SmPC sections updated: 4.2, 4.4, 4.8, 4.9 and 10
Last updated on this site: 29 May 2026
Description of update:
1: To update sections 4.4 and 4.8 of the SmPC and PIL of the finished products Gabapentin Accord hard capsules to bring the product information in line with PRAC update (PSUSA/00001499/202502) - for causal relationship between gabapentin and withdrawal reactions following dose reduction, and exacerbation of myasthenia gravis.
2: To update sections 4.2, 4.4, 4.8 and 4.9 of the SmPC of the finished products in line with MHRA review to improve communication of risks. Consequently, the label and PIL are also being updated accordingly. In addition, editorial updates have been made to the PIL and cartons including QRD updates to the PIL.
Date of approval: 02/04/2026
PIL sections updated: Heading, headline, 1, 2, 3, 4, 5 and 6
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintFor any further assistance, please get in touch.